title: [New trends and novel possibilities in the management of oncologic patients: clinical uses of PET/MRI].
abstract: The most recent multimodality technique, the hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) combines two very different technologies, which is a great result of human creativity. The combined PET/MRI has significant potentials in clinical oncology providing new perspectives of functional and anatomical information. PET/MRI offers simultaneous measurements of multifunctional data such as PET mapping by different specific tracers or MRI morphologic, MR molecular (MR spectroscopy, MRS), or MR functional (fMR) information of a living system.
authors.affiliation: PET/CT Ambulancia, Országos Onkológiai Intézet, Budapest, Hungary. katalin.borbely@oncol.hu.
authors.forename: Katalin
authors.initials: K
authors.lastname: Borbély
mesh_terms: D000008:Abdominal Neoplasms / Q000175:diagnosis; D019468:Disease Management; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism; D006258:Head and Neck Neoplasms / Q000175:diagnosis; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods / Q000592:standards / Q000639:trends; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008495:Medical Oncology / Q000379:methods; D064847:Multimodal Imaging / Q000379:methods*; D009369:Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology; D010051:Ovarian Neoplasms / Q000175:diagnosis; D049268:Positron-Emission Tomography / Q000379:methods / Q000592:standards / Q000639:trends; D011471:Prostatic Neoplasms / Q000175:diagnosis; D019275:Radiopharmaceuticals / Q000378:metabolism; D012004:Rectal Neoplasms / Q000175:diagnosis; D013899:Thoracic Neoplasms / Q000175:diagnosis
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18